Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Conditions studied

Breast Carcinoma, Esophageal Carcinoma, Genitourinary System Carcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Lung Carcinoma, Malignant Central Nervous System Neoplasm, Malignant Digestive System Neoplasm, Malignant Solid Neoplasm

About this study

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Interventions

• Other: Quality-of-Life Assessment — Complete questionnaires
• Other: Questionnaire Administration — Complete questionnaires

Primary outcomes

• Acute toxicities data in patients treated with proton therapy (Up to 90 days after end of treatment)
• Late toxicities data in patients treated with proton therapy (Starting 90 days or more after the end of radiotherapy)
• Dose-response relationships for normal tissue toxicity after proton therapy (Up to 3 months after therapy)

Eligibility information

Study locations

• M D Anderson Cancer Center, Houston, Texas 77030 United States